XENE Heads Into Q1 Print With Shorts in Retreat
Xenon Pharmaceuticals enters its June 2 earnings call in an unusual position: short sellers have been cutting exposure for a month, analysts keep raising targets, and yet the stock trades roughly 14% below the Street…
